121 related articles for article (PubMed ID: 17260585)
21. Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients.
Cattani F; Vavassori A; Comi S; Gherardi F; Russo S; Orecchia R; Jereczek-Fossa BA
Phys Med; 2017 Aug; 40():66-71. PubMed ID: 28743617
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
[TBL] [Abstract][Full Text] [Related]
23. Sector analysis of 125I permanent prostate brachytherapy provides a rapid and effective method of evaluating and comparing pre- and post-implant dosimetry.
Mohamed Yoosuf AB; Workman G; O'Toole MM; Straney M; Verghis R; Napier E; Mitchell DM
Brachytherapy; 2013; 12(3):254-9. PubMed ID: 23406986
[TBL] [Abstract][Full Text] [Related]
24. [Iodine-125 transperineal prostate brachytherapy with preplanning technique: pre and post-implant dosimetry results analysis].
Simonian-Sauve M; Smart C; Mailleux H; Rosello R; Bladou F; Salem N
Cancer Radiother; 2003 Apr; 7(2):90-9. PubMed ID: 12719038
[TBL] [Abstract][Full Text] [Related]
25. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
26. The dependence of prostate postimplant dosimetric quality on CT volume determination.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1111-7. PubMed ID: 10421545
[TBL] [Abstract][Full Text] [Related]
27. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
[TBL] [Abstract][Full Text] [Related]
29. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
Lee WR; deGuzman AF; Bare RL; Marshall MG; McCullough DL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):83-8. PubMed ID: 10656377
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
Stock RG; Stone NN; Lo YC
Tech Urol; 2000 Jun; 6(2):95-8. PubMed ID: 10798807
[TBL] [Abstract][Full Text] [Related]
31. CT-based dosimetry for transperineal I-125 prostate brachytherapy.
Willins J; Wallner K
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):347-53. PubMed ID: 9308938
[TBL] [Abstract][Full Text] [Related]
32. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
[TBL] [Abstract][Full Text] [Related]
33. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
34. Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.
Girum KB; Lalande A; Quivrin M; Bessières I; Pierrat N; Martin E; Cormier L; Petitfils A; Cosset JM; Créhange G
Brachytherapy; 2018; 17(6):866-873. PubMed ID: 30217431
[TBL] [Abstract][Full Text] [Related]
35. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
36. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
Prete JJ; Prestidge BR; Bice WS; Friedland JL; Stock RG; Grimm PD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):1001-5. PubMed ID: 9531387
[TBL] [Abstract][Full Text] [Related]
37. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
38. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
39. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution.
Rutten TP; Lawson JM; Marcu LG
Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428
[TBL] [Abstract][Full Text] [Related]
40. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy.
Zelefsky MJ; Cohen GN; Bosch WR; Morikawa L; Khalid N; Crozier CL; Lee WR; Zietman A; Owen J; Wilson JF; Devlin PM
Brachytherapy; 2013; 12(1):19-24. PubMed ID: 22819388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
